Flutikrit F 500 Capsule is a combination medication containing Formoterol (12mcg) and Fluticasone Propionate (500mcg), designed for the management and prevention of asthma and chronic obstructive pulmonary disease (COPD). Formoterol is a long-acting beta2-adrenergic agonist (LABA) that works by relaxing the muscles in the airways, leading to bronchodilation and improved airflow, thereby reducing symptoms such as wheezing, shortness of breath, and coughing. Fluticasone Propionate is a corticosteroid that helps to reduce inflammation and swelling in the airways, preventing asthma attacks and exacerbations of COPD. Together, these active ingredients provide both immediate and sustained relief from respiratory symptoms while controlling underlying inflammation. Flutikrit F 500 Capsule is typically prescribed for patients who require regular maintenance therapy to manage persistent asthma or moderate to severe COPD. It is important to use this medication exactly as directed by a healthcare professional, as improper use may increase the risk of side effects such as oral thrush, hoarseness, or increased heart rate. Patients should not use this capsule for acute asthma attacks and should consult their doctor if symptoms worsen or if they experience any adverse reactions. Regular monitoring and adherence to prescribed dosage ensure optimal therapeutic outcomes with Flutikrit F 500 Capsule.